Anika, Fidia Farmaceutici S.p.A. deal

Anika acquired Fidia's Fidia Advanced Biopolymers s.r.l. subsidiary in a cash and stock deal valued at $33.9 million. The deal includes $17.1 million in cash and about 2 million Anika shares valued at $16.8 million based on Anika's close of $8.49 on Dec. 30, 2009, the day before the deal was announced. Anika gains Fidia's Hyalograft C hyaluronan biopolymer scaffold. The cell culture matrix is marketed in Europe for cartilage repair. The subsidiary recorded 2009 revenues of $11.1 million. ...